An involvement of TNFα and IL-1β in the activation of YAP and TAZ in mouse adipocytes during obesity could be demonstrated by treating animals with the TNFα inhibitor etanercept and the IL-1β inhibitor anakinra. The gene discussed is YAP1; the disease is obesity disorder.